Skip to content

Pediatric Veins Cannulation Technique

Peripheral Veins Cannulation in Children Using Veinsite: a Randomized Clinical Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02918604
Enrollment
80
Registered
2016-09-29
Start date
2015-01-31
Completion date
2016-05-31
Last updated
2016-09-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Successful Vein Cannulation at First Attempt

Keywords

peripheral vein access, infrared, pediatric

Brief summary

multicenter, prospective and cohort study to evaluate infrared technology for identifying and and indwelling peripheral veins in 0 up to 4 years old children.

Detailed description

AIM OF THE STUDY The primary objective of this study is to determine the success rate at first attempt of peripheral veins cannulation in small children (\<5yrs) and infants (\<1yr) of Veinsite compared with traditional palpation method performed by skilled operators. The secondary objective of this study is to determine the time to cannulation using the two techniques, the difference in visualized veins using the Veinsite or the direct visualization and palpation of the patients' skin, cannula indwelling time and complications related to the procedure. DESIGN Prospective randomized controlled study Population It is expected to recruit 60 pediatric patients undergoing peripheral vein cannulation with known difficulties according the difficult venous access score (DIVA) (6) in the following centers: 1. Fondazione IRCCS Istituto Neurologico C.Besta , Milano 2. Ospedale Pediatrico Bambino Gesù, IRCCS, Roma Duration of study Patient will be followed from the day of peripheral vein cannulation till the peripheral cannula will be removed (max 3 days) in order to assess any cause of venous extravasation. The recruitment phase is supposed to be 6 months after achieving the ethical-administrative authorization.

Interventions

DEVICEinfrared technology: Veinsite

peripheral vein access performed with Veinsite support by expert paediatric anaesthesiologists and intensivists

Sponsors

Bambino Gesù Hospital and Research Institute
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
No minimum to 4 Years
Healthy volunteers
No

Inclusion criteria

* Male and Female children from 1 month to 5 years Of age * American Society of Anesthesiologists Classification (ASA) I: without systemic disease * American Society of Anesthesiologists Classification (ASA) II: moderate systemic disease * American Society of Anesthesiologists Classification (ASA) III: severe systemic disease that limits normal activity, without invalidity. * Scheduled for any indication of peripheral venous line placement * Admission to an Intensive Care Unit, Neurosurgery ward or pediatric ward of one of the hospitals included * Children whose parents (or legal tutors) have given their informed written consent

Exclusion criteria

* Any contraindication for peripheral line placement * Children whose parents (or legal tutors) denied their own consensus

Design outcomes

Primary

MeasureTime frameDescription
success of peripheral vein access positioning2 yearto determine the success rate at first attempt of peripheral veins cannulation in small children (\<5yrs) and infants (\<1yr) of Veinsite compared with traditional palpation method performed by skilled operators.

Secondary

MeasureTime frameDescription
impact of DIVA score(difficult vein access score) on time of success number of participants with treatment-related peripheral vein cannulation failure2 yearof this study is to determine the time to cannulation using the two techniques, the difference in visualized veins using the Veinsite or the direct visualization and palpation of the patients' skin, cannula indwelling time and complications related to the procedure.

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026